Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidisciplinary treatment for macrometastatic osteogenic sarcoma.

N Jaffe, D Traggis, J R Cassady

    British Medical Journal
    |October 30, 1976
    PubMed
    Summary

    A multidisciplinary approach including surgery, radiation, and chemotherapy significantly improved outcomes for osteogenic sarcoma patients with metastases. High-dose methotrexate showed efficacy in tumor regression and maintenance therapy, offering better results than historical controls.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines.

    International journal of clinical pharmacology and therapeutics·2002
    Same author

    Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

    Anti-cancer drug design·2002
    Same author

    The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
    Same author

    Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

    General physiology and biophysics·2002
    Same author

    The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.

    Biochemical pharmacology·2002
    Same author

    Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation.

    General physiology and biophysics·2002

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Medical Oncology
    • Radiation Oncology

    Background:

    • Osteogenic sarcoma is a primary bone cancer that frequently metastasizes.
    • Metastatic osteogenic sarcoma has historically had a poor prognosis.
    • Effective treatment strategies for metastatic osteogenic sarcoma are crucial.

    Purpose of the Study:

    • To evaluate the efficacy of a multidisciplinary treatment approach for osteogenic sarcoma with metastases.
    • To assess the role of high-dose methotrexate in managing metastatic osteogenic sarcoma.
    • To compare outcomes with a historical control group.

    Main Methods:

    • A coordinated multidisciplinary approach involving surgery, radiation therapy, and chemotherapy.

    Related Experiment Videos

  • Administration of weekly high-dose methotrexate for tumor regression.
  • Maintenance therapy with high-dose methotrexate every 2-3 weeks post-disease removal.
  • Comparison with a historical control group of 82 patients.

    • Main Results:

    • 14 out of 21 patients achieved disease-free status for over 2 to 18 months.
    • High-dose methotrexate induced tumor regression in 7 out of 15 patients.
    • The study group showed significantly better results compared to the historical control group.

    Conclusions:

    • A multidisciplinary approach combining surgery, radiation, and chemotherapy is effective for metastatic osteogenic sarcoma.
    • High-dose methotrexate demonstrates efficacy in inducing tumor regression and serves as valuable maintenance therapy.
    • These findings suggest a promising treatment paradigm for metastatic osteogenic sarcoma, potentially comparable to advances seen in Wilms' tumor.